Suppr超能文献

恶性血液病患者化疗所致发热性中性粒细胞减少期间血流感染的评估:单中心经验

Evaluation of Bloodstream Infections During Chemotherapy-Induced Febrile Neutropenia in Patients with Malignant Hematological Diseases: Single Center Experience.

作者信息

Piukovics Klára, Terhes Gabriella, Lázár Andrea, Tímár Flóra, Borbényi Zita, Urbán Edit

机构信息

Second Department of Internal Medicine and Cardiological Center, University of Szeged , Szeged, Hungary.

Institute of Clinical Microbiology, University of Szeged , Szeged, Hungary.

出版信息

Eur J Microbiol Immunol (Bp). 2015 Sep 18;5(3):199-204. doi: 10.1556/1886.2015.00021. eCollection 2015 Sep.

Abstract

From year to year, it is important to get an overview of the occurrence of causative agents in febrile neutropenic patients to determine the empiric treatment. Thus our aims were to evaluate a four-year period regarding the prevalence of bloodstream infections and the most important causative agents. During this period, 1,361 patients were treated in our hematology ward because of various hematological disorders. 812 febrile episodes were recorded in 469 patients. At that time, 3,714 blood culture (BC) bottles were sent for microbiological investigations, 759 of them gave positive signal. From the majority of positive blood culture bottles (67.1%), Gram-positive bacteria, mainly coagulase-negative staphylococci (CNS), were grown. Gram-negative bacteria were isolated from 32.9% of the positive blood culture bottles, in these cases the leading pathogen was Escherichia coli. The high prevalence of CNS was attributed to mainly contamination, while lower positivity rate for Gram-negative bacteria was associated with the use of broad-spectrum empiric antibiotic treatment.

摘要

逐年了解发热性中性粒细胞减少患者中病原体的发生情况对于确定经验性治疗很重要。因此,我们的目的是评估四年期间血流感染的患病率以及最重要的病原体。在此期间,我们血液科病房因各种血液系统疾病治疗了1361例患者。469例患者记录了812次发热发作。当时,共送检了3714瓶血培养(BC)进行微生物学检查,其中759瓶发出阳性信号。大多数阳性血培养瓶(67.1%)培养出革兰氏阳性菌,主要是凝固酶阴性葡萄球菌(CNS)。32.9%的阳性血培养瓶分离出革兰氏阴性菌,这些病例中主要病原体是大肠杆菌。CNS的高患病率主要归因于污染,而革兰氏阴性菌较低的阳性率与使用广谱经验性抗生素治疗有关。

相似文献

1
7
Current time-to-positivity of blood cultures in febrile neutropenia: a tool to be used in stewardship de-escalation strategies.
Clin Microbiol Infect. 2019 Apr;25(4):447-453. doi: 10.1016/j.cmi.2018.07.026. Epub 2018 Aug 7.
8
Evaluation of febrile neutropenic attacks of pediatric hematology-oncology patients.
Turk Pediatri Ars. 2017 Dec 1;52(4):213-220. doi: 10.5152/TurkPediatriArs.2017.5312. eCollection 2017 Dec.
10
Using teicoplanin for empiric therapy of febrile neutropenic patients with haematological malignancies.
Br J Haematol. 1990 Dec;76 Suppl 2:45-8. doi: 10.1111/j.1365-2141.1990.tb07936.x.

引用本文的文献

7
Timing of Blood Cultures in the Setting of Febrile Neutropenia: An Australian Institutional Experience.
Turk J Haematol. 2021 Feb 25;38(1):57-63. doi: 10.4274/tjh.galenos.2020.2020.0302. Epub 2020 Oct 15.
8
Clinical Significance of Isolates Known to Be Blood Culture Contaminants in Pediatric Patients.
Medicina (Kaunas). 2019 Oct 17;55(10):696. doi: 10.3390/medicina55100696.
9
Viridans group streptococci bloodstream infections in neutropenic adult patients with hematologic malignancy: Single center experience.
Folia Microbiol (Praha). 2018 Mar;63(2):141-146. doi: 10.1007/s12223-017-0542-7. Epub 2017 Aug 3.

本文引用的文献

1
Febrile neutropenia in hematologic malignancies.
Curr Hematol Malig Rep. 2013 Dec;8(4):370-8. doi: 10.1007/s11899-013-0171-4.
2
Blood stream infections during chemotherapy-induced neutropenia in adult patients with acute myeloid leukemia: treatment cycle matters.
Eur J Clin Microbiol Infect Dis. 2010 Oct;29(10):1211-8. doi: 10.1007/s10096-010-0984-1. Epub 2010 Jun 17.
4
Antibiotic prophylaxis for patients with acute leukemia.
Leuk Lymphoma. 2008 Feb;49(2):183-93. doi: 10.1080/10428190701769673.
5
Bacteraemia in febrile neutropenic cancer patients.
Int J Antimicrob Agents. 2007 Nov;30 Suppl 1:S51-9. doi: 10.1016/j.ijantimicag.2007.06.012. Epub 2007 Aug 8.
6
Piperacillin-tazobactam monotherapy in high-risk febrile and neutropenic cancer patients.
Clin Microbiol Infect. 2006 Mar;12(3):212-6. doi: 10.1111/j.1469-0691.2005.01297.x.
7
Prophylactic antimicrobial agents and the importance of fitness.
N Engl J Med. 2005 Sep 8;353(10):1052-4. doi: 10.1056/NEJMe058133.
8
New developments in the diagnosis of bloodstream infections.
Lancet Infect Dis. 2004 Dec;4(12):751-60. doi: 10.1016/S1473-3099(04)01205-8.
10
Management of the febrile neutropenic patient: a consensus conference.
Clin Infect Dis. 2004 Jul 15;39 Suppl 1:S1-6. doi: 10.1086/383041.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验